RedShiftBio

📍 Boxborough, United States🗓 Founded 2005👥 28 employees💰 Last funded Oct 2021
Biotechnology Research🌐 redshiftbio.com
Website LinkedIn
RedShiftBio is redefining the possibilities for structural characterization of biomolecules. RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high powered quantum cascade lasers that provides ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. This combination of technologies is available to researchers in our fully-automated AQS³pro Analyzer and is backed by a global network of sales, applications, service, and support teams to address all market needs. Led by an experienced management team with a proven track record of success in both large instrumentation companies and commercializing disruptive technologies, RedShiftBio is here to support your research and development goals. Our instruments can be found in the majority of the leading biopharmaceutical companies in the world.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in RedShiftBio?
RedShiftBio has 1 investors on record on gritt.io.
When did RedShiftBio last raise funding?
The most recent investment in RedShiftBio recorded on gritt.io was in October 2021.
When was RedShiftBio founded?
RedShiftBio was founded in 2005.
What industry is RedShiftBio in?
RedShiftBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is RedShiftBio based?
RedShiftBio is headquartered in Boxborough, United States.